Graft and Patient Survival Rate among Iranian Pediatric Recipients of Kidney Transplantation: A Systematic Review and

Ahmad Shajari1, Mohammad Moein Ashrafi2, Hamideh Shajari3

  • 1Ali-Ebne-Abitaleb School of Medicine, Yazd Branch, Islamic Azad University, Yazd, Iran.

Insights

This systematic review and meta-analysis evaluated kidney transplant survival rates in Iranian children with end-stage renal disease (ESRD). Pediatric kidney transplant survival rates at 1, 5, and 10 years were 91%, 81%, and 70% respectively.

Area of Science:

  • Pediatric Nephrology
  • Transplantation Immunology
  • Public Health

Background:

  • End-Stage Renal Disease (ESRD) necessitates long-term alternative therapies, particularly in pediatric patients.
  • Kidney transplantation is a critical treatment for children with ESRD, requiring evaluation of long-term outcomes.
  • Assessing graft and patient survival rates is crucial for optimizing pediatric kidney transplant care.

Purpose of the Study:

  • To evaluate graft and patient survival rates in Iranian pediatric kidney transplant recipients.
  • To provide a comprehensive evidence base for planning and policy-making in pediatric kidney transplantation.
  • To estimate survival rates for children undergoing kidney transplantation in Iran.

Main Methods:

  • A systematic review and meta-analysis of studies on pediatric kidney transplantation in Iran.
  • Searched national and international databases (1985-Nov 2019) including PubMed, Scopus, Web of Science, Cochrane.
  • Analyzed data from 10 studies involving 2673 pediatric recipients using random-effects modeling and meta-regression.

Main Results:

  • The study included 2673 pediatric kidney transplant recipients with an average age of 13.71 years.
  • Estimated survival rates for kidney transplantation were 91% at 1 year, 88% at 3 years, 81% at 5 years, and 70% at 10 years.
  • Meta-regression explored factors influencing heterogeneity in survival rates across different cities.

Conclusions:

  • The findings provide documented evidence on pediatric kidney transplant survival in Iran.
  • Results can inform health policy, treatment program evaluation, and intervention planning for pediatric kidney transplantation.
  • The study offers valuable insights for improving outcomes and resource allocation in pediatric renal replacement therapy.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
36
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
52
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
59
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
469
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
392
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
59